PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Viale Mario Bracci, 16, Siena, Italy. maio@unisi.it.\', \'Italian Network for Tumor Bio-Immunotherapy Foundation Onlus, Siena, Italy. maio@unisi.it.\', \'iOnctura SA, Avenue Secheron 15, Geneva, Switzerland.\', \'Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Viale Mario Bracci, 16, Siena, Italy.\', \'Italian Network for Tumor Bio-Immunotherapy Foundation Onlus, Siena, Italy.\', \'Parker Institute for Cancer Immunotherapy, 1 Letterman Drive, San Francisco, 94012, USA.\', \'Earle A. Chiles Research Institute at the Robert W. Franz Cancer Center, 4805 NE Glisan St. Suite 2N35, Portland, OR, 97213, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13046-021-02023-4
?:hasPublicationType
?:journal
  • Journal of experimental & clinical cancer research : CR
is ?:pmid of
?:pmid
?:pmid
  • 34301276
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all